Literature DB >> 26489742

Venous Thromboembolism Prophylaxis in Liver Surgery.

Thomas A Aloia, William H Geerts, Bryan M Clary, Ryan W Day, Alan W Hemming, Luiz Carneiro D'Albuquerque, Charles M Vollmer, Jean-Nicolas Vauthey, Giles J Toogood.   

Abstract

BACKGROUND: At a recently concluded Americas Hepato-Pancreato-Biliary Association Annual Meeting, a Clinical Practice Guidelines Conference Series was convened with the topic focusing on Venous Thromboembolism (VTE) Prophylaxis in Liver Surgery. The symposium brought together hepatobiliary surgeons from three continents as well as medical experts in hematology and coagulation.
METHODS: The content of the discussion included literature reviews, evaluation of multi-institutional VTE outcome data, and examination of practice patterns at multiple high-volume centers.
RESULTS: Literature review demonstrated that, within gastrointestinal surgery, liver resection patients are at particularly high-risk for VTE. Recent evidence clearly indicates a direct relationship between the magnitude of hepatectomy and postoperative VTE rates, however, the PT/INR does not accurately reflect the coagulation status of the post-hepatectomy patient. Evaluation of available data and practice patterns regarding the utilization and timing of anticoagulant VTE prophylaxis led to recommendations regarding preoperative and postoperative thromboprophylaxis for liver surgery patients.
CONCLUSIONS: This conference was effective in consolidating our knowledge of coagulation abnormalities after liver resection. Based on the expert review of the available data and practice patterns, a number of recommendations were developed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26489742     DOI: 10.1007/s11605-015-2902-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  45 in total

1.  Revisiting the issue of VTE in the setting of chronic liver disease: an examination of National Surgical Quality Improvement Program data.

Authors:  Jason Schwartz; Gabriela Vargas; Heather Thiesset; Greg Stoddard; Robin Kim; John Sorensen; Larry Kraiss
Journal:  Chest       Date:  2011-06       Impact factor: 9.410

2.  Defining incidence and risk factors of venous thromboemolism after hepatectomy.

Authors:  Aslam Ejaz; Gaya Spolverato; Yuhree Kim; Donald L Lucas; Brandyn Lau; Matthew Weiss; Fabian M Johnston; Marin Kheng; Marian Kheng; Kenzo Hirose; Christopher L Wolfgang; Elliott Haut; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-12-13       Impact factor: 3.452

Review 3.  Haemostasis and thrombosis in liver disease.

Authors:  Lara N Roberts; Raj K Patel; Roopen Arya
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

4.  The international normalized ratio overestimates coagulopathy in patients after major hepatectomy.

Authors:  Scott G Louis; Jeffrey S Barton; Gordon M Riha; Susan L Orloff; Brett C Sheppard; Rodney F Pommier; Samantha J Underwood; Jerome A Differding; Martin A Schreiber; Kevin G Billingsley
Journal:  Am J Surg       Date:  2014-03-12       Impact factor: 2.565

5.  Venous thromboembolism after hepatic resection: analysis of 5,706 patients.

Authors:  Ryan S Turley; Srinevas K Reddy; Cynthia K Shortell; Bryan M Clary; John E Scarborough
Journal:  J Gastrointest Surg       Date:  2012-06-30       Impact factor: 3.452

6.  A validation study of a retrospective venous thromboembolism risk scoring method.

Authors:  Vinita Bahl; Hsou Mei Hu; Peter K Henke; Thomas W Wakefield; Darrell A Campbell; Joseph A Caprini
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

7.  Coagulopathy after a liver resection: is it over diagnosed and over treated?

Authors:  Jeffrey S Barton; Gordon M Riha; Jerome A Differding; Samantha J Underwood; Jodie L Curren; Brett C Sheppard; Rodney F Pommier; Susan L Orloff; Martin A Schreiber; Kevin G Billingsley
Journal:  HPB (Oxford)       Date:  2013-01-29       Impact factor: 3.647

8.  An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Authors:  Armando Tripodi; Massimo Primignani; Veena Chantarangkul; Alessandra Dell'Era; Marigrazia Clerici; Roberto de Franchis; Massimo Colombo; Pier Mannuccio Mannucci
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

Review 9.  Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.

Authors:  A Tripodi; S H Caldwell; M Hoffman; J F Trotter; A J Sanyal
Journal:  Aliment Pharmacol Ther       Date:  2007-07-15       Impact factor: 8.171

10.  Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database.

Authors:  Thomas A Aloia; Bridget N Fahy; Craig P Fischer; Stephen L Jones; Andrea Duchini; Joseph Galati; A Osama Gaber; R Mark Ghobrial; Barbara L Bass
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

View more
  10 in total

1.  Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Authors:  B J Kim; R W Day; C H Davis; N Narula; M H Kroll; C W D Tzeng; T A Aloia
Journal:  J Thromb Haemost       Date:  2017-09-27       Impact factor: 5.824

2.  Response to Comment on: Early recovery pathway for hepatectomy: data-driven liver resection care and recovery.

Authors:  Susanne G Warner; Zeljka Jutric; Yuman Fong
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

3.  Comment on: Early recovery pathway for hepatectomy: data-driven liver resection care and recovery.

Authors:  Annabel Blasi; Joan Beltran
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

4.  Post-hepatectomy venous thromboembolism: a systematic review with meta-analysis exploring the role of pharmacological thromboprophylaxis.

Authors:  Monish Karunakaran; Ramneek Kaur; Simi Ismail; Sushma Cherukuru; Pavan Kumar Jonnada; Baiju Senadhipan; Savio George Barreto
Journal:  Langenbecks Arch Surg       Date:  2022-07-26       Impact factor: 2.895

5.  What Is "Enhanced Recovery," and How Can I Do It?

Authors:  Bradford J Kim; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2017-10-24       Impact factor: 3.452

6.  Patient Adherence and Experience with Extended Use of Prophylactic Low-Molecular-Weight Heparin Following Pancreas and Liver Resection.

Authors:  Madeline Lemke; Kaitlyn Beyfuss; Julie Hallet; Natalie G Coburn; Calvin H L Law; Paul J Karanicolas
Journal:  J Gastrointest Surg       Date:  2016-09-29       Impact factor: 3.452

7.  Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer.

Authors:  M Farzan Rashid; Terri L Jackson; Jheanell A Morgan; Franklin A Dwyer; Beth A Schrope; John A Chabot; Michael D Kluger
Journal:  J Gastrointest Surg       Date:  2018-09-05       Impact factor: 3.452

8.  Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event.

Authors:  Oladapo Adaramola; Nadia Solomon; Fortune Anyanwu; Abelard Desrosiers; Mathew Smith
Journal:  Radiol Case Rep       Date:  2020-06-27

9.  Development and validation of a risk calculator for post-discharge venous thromboembolism following hepatectomy for malignancy.

Authors:  Cary Jo R Schlick; Ryan J Ellis; Ryan P Merkow; Anthony D Yang; David J Bentrem
Journal:  HPB (Oxford)       Date:  2020-09-26       Impact factor: 3.647

10.  Post-discharge venous thromboembolism after pancreatectomy for malignancy: Predicting risk based on preoperative, intraoperative, and postoperative factors.

Authors:  Cary Jo R Schlick; Ryan P Merkow; Anthony D Yang; David J Bentrem
Journal:  J Surg Oncol       Date:  2020-06-12       Impact factor: 3.454

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.